Dane Leone

Stock Analyst at Raymond James

(1.16)
# 3,774
Out of 5,045 analysts
69
Total ratings
33.96%
Success rate
-7.04%
Average return

Stocks Rated by Dane Leone

Relay Therapeutics
Aug 8, 2025
Maintains: Strong Buy
Price Target: $29$19
Current: $7.34
Upside: +158.86%
Xilio Therapeutics
Nov 8, 2024
Maintains: Outperform
Price Target: $6$4
Current: $0.80
Upside: +397.76%
REGENXBIO
Feb 21, 2024
Reinstates: Outperform
Price Target: $45
Current: $12.82
Upside: +251.01%
Revolution Medicines
Nov 16, 2023
Initiates: Outperform
Price Target: $30
Current: $58.87
Upside: -49.04%
Regeneron Pharmaceuticals
Nov 3, 2023
Upgrades: Outperform
Price Target: $950
Current: $654.04
Upside: +45.25%
Nkarta
Oct 18, 2023
Upgrades: Strong Buy
Price Target: $13
Current: $2.08
Upside: +525.00%
BridgeBio Pharma
Jul 18, 2023
Maintains: Outperform
Price Target: $29$46
Current: $63.37
Upside: -27.41%
Galapagos NV
May 8, 2023
Upgrades: Outperform
Price Target: $69
Current: $31.34
Upside: +120.17%
Compass Therapeutics
Nov 10, 2022
Maintains: Outperform
Price Target: $5$8
Current: $3.72
Upside: +115.05%
Ocular Therapeutix
Nov 8, 2022
Maintains: Strong Buy
Price Target: $29$14
Current: $11.82
Upside: +18.44%
Upgrades: Strong Buy
Price Target: $58
Current: $14.13
Upside: +310.47%
Maintains: Outperform
Price Target: $54$70
Current: $17.16
Upside: +307.93%
Downgrades: Market Perform
Price Target: n/a
Current: $1.21
Upside: -
Maintains: Outperform
Price Target: $54$63
Current: $62.25
Upside: +1.20%
Downgrades: Market Perform
Price Target: n/a
Current: $45.62
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $1.49
Upside: -
Maintains: Strong Buy
Price Target: $50$65
Current: $68.96
Upside: -5.74%
Upgrades: Outperform
Price Target: $255
Current: $292.00
Upside: -12.67%
Assumes: Buy
Price Target: $32
Current: $4.52
Upside: +607.96%
Downgrades: Sell
Price Target: n/a
Current: $189.05
Upside: -